Literature DB >> 19906230

Glucocorticoids. Mood, memory, and mechanisms.

Owen M Wolkowitz1, Heather Burke, Elissa S Epel, Victor I Reus.   

Abstract

Elevated circulating levels of glucocorticoids are associated with psychiatric symptoms across several different conditions. It remains unknown if this hormonal abnormality is a cause or an effect of the psychiatric conditions. For example, the hypercortisolemia observed in a subset of patients with depression may have a direct impact on the symptoms of depression, but it is also possible that the hypercortisolemia merely reflects the stress associated with depression. Further, rather than causing depression, hypercortisolemia could represent a homeostatic attempt to overcome glucocorticoid resistance. Each of these possibilities will be considered, and correlational and causal evidence will be reviewed. This article will focus on the relationships between glucocorticoids and psychiatric symptoms in Cushing's syndrome, major depression, and steroid psychosis/steroid dementia, as well as the effects of exogenously administered glucocorticoids in normal volunteers. Similarities and differences in the relationship of glucocorticoid hormones to psychiatric symptoms in these conditions will be reviewed. Possible mediators of glucocorticoid effects on the brain and behavior, as well as possible "pro-aging" effects of glucocorticoids in certain cells of the body, will be reviewed. The article concludes with a conceptual model of glucocorticoid actions in the brain that may lead to novel therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906230     DOI: 10.1111/j.1749-6632.2009.04980.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  57 in total

Review 1.  Cortisol and finfish welfare.

Authors:  Tim Ellis; Hijran Yavuzcan Yildiz; Jose López-Olmeda; Maria Teresa Spedicato; Lluis Tort; Øyvind Øverli; Catarina I M Martins
Journal:  Fish Physiol Biochem       Date:  2011-11-24       Impact factor: 2.794

Review 2.  Corticosteroids and Cognition: A Meta-Analysis.

Authors:  Catherine E Prado; Simon F Crowe
Journal:  Neuropsychol Rev       Date:  2019-05-26       Impact factor: 7.444

Review 3.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

4.  Expression profiles of the nuclear receptors and their transcriptional coregulators during differentiation of neural stem cells.

Authors:  A Androutsellis-Theotokis; G P Chrousos; R D McKay; A H DeCherney; T Kino
Journal:  Horm Metab Res       Date:  2012-09-18       Impact factor: 2.936

5.  Acute cognitive and behavioral effects of systemic corticosteroids in children treated for inflammatory bowel disease.

Authors:  Christine Mrakotsky; Peter W Forbes; Jane Holmes Bernstein; Richard J Grand; Athos Bousvaros; Eva Szigethy; Deborah P Waber
Journal:  J Int Neuropsychol Soc       Date:  2012-11-19       Impact factor: 2.892

Review 6.  Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.

Authors:  Gloria Laryea; Lisa Muglia; Melinda Arnett; Louis J Muglia
Journal:  Front Neuroendocrinol       Date:  2014-09-27       Impact factor: 8.606

7.  Time Course of Behavioral Alteration and mRNA Levels of Neurotrophic Factor Following Stress Exposure in Mouse.

Authors:  Naoya Hashikawa; Takumi Ogawa; Yusuke Sakamoto; Mami Ogawa; Yumi Matsuo; Yoshito Zamami; Narumi Hashikawa-Hobara
Journal:  Cell Mol Neurobiol       Date:  2015-03-28       Impact factor: 5.046

Review 8.  Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Authors:  Samir D Bhangle; Neil Kramer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

9.  A randomized, placebo-controlled proof-of-concept, crossover trial of phenytoin for hydrocortisone-induced declarative memory changes.

Authors:  E Sherwood Brown; Hanzhang Lu; Daren Denniston; Jinsoo Uh; Binu P Thomas; Thomas J Carmody; Richard J Auchus; Ramon Diaz-Arrastia; Carol Tamminga
Journal:  J Affect Disord       Date:  2013-02-28       Impact factor: 4.839

10.  Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy.

Authors:  Suk-Young Lee; Naoki Kurita; Yasuhisa Yokoyama; Masanori Seki; Yuichi Hasegawa; Yasushi Okoshi; Shigeru Chiba
Journal:  Support Care Cancer       Date:  2013-12-21       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.